YOUR BUSINESS AUTHORITY
Springfield, MO
Drugmaker Regeneron Pharmaceuticals is set to buy genetic testing firm 23andMe through bankruptcy proceedings.
The deal is valued at $256 million.
23andMe has collected genetic data from some 15 million customers.
Read more from Reuters.
This installment of Springfield Business Journal’s Architects & Engineers Project Report showcases 26 endeavors by area design and engineering professionals.
Longtime employee sues Ozarks Tech, alleges retaliation
Cavender’s opens hat shop in southeast Springfield
Eric Schmitt introduces Modern Skies Act
Caterpillar to acquire John Fabick Tractor Co.
Springfield airport to cut the ribbon on $35M in construction projects
Legacy Bank accused in lawsuit of failing to protect customers in data breach